NEW YORK, Oct. 25 (GenomeWeb News) - Affymetrix and CureSearch Children's Oncology Group will jointly research gene-expression signatures for childhood cancers, Affymetrix said today.
Affymetrix will use its GeneChip microarray technology for this effort. COG has an existing databank of more than 20,000 tumor samples.
COG scientists will use Affymetrix microarrays to find similarly expressed genes amongst a group of children sharing the same disease. The identified genetic fingerprint will allow physicians to test other patients for common pediatric cancers, including leukemia and sarcoma.
Additional details were not disclosed.